Big promises? Questionable stem cell therapies marketed to heart failure patients – Cardiovascular Business
|
Big promises? Questionable stem cell therapies marketed to heart failure patients
Cardiovascular Business The U.S. Food and Drug Administration (FDA) is examining potential benefits from stem cell therapies for individuals with heart failure, though it has not approved any. Regardless, more than 500 businesses in the U.S. are marketing the benefits of stem … |
